Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
University of Maryland, BaltimoreIntegra LifeSciences CorporationCompleted
-
PfizerCompletedCarcinoma, Metastatic BreastUnited States
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
National Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Fallopian Tube Carcinoma | Triple-Negative Breast Carcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Ovarian Serous Surface Papillary AdenocarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedBreast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor NegativeUnited States, Guam
-
University of Southern CaliforniaStanford UniversityCompletedHereditary Breast and Ovarian CancerUnited States
-
Washington University School of MedicineMusculoskeletal Transplant FoundationCompletedVentral Hernia | Post-mastectomy Breast ReconstructionUnited States
-
PfizerCompletedBreast NeoplasmsCanada, United States, France, Spain, Belgium
-
University of UtahCompletedNewly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast CancerUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedTreating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (BMS-247550)Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Aminex Therapeutics, Inc.RecruitingMelanoma (Skin Cancer) | HER2-low Hormone Receptor Positive Breast CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationBreast Cancer | Ovarian Cancer | Uterine CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Atossa Therapeutics, Inc.Covance; Illumina, Inc.CompletedBreast Cancer | Ductal Carcinoma in Situ | Preneoplastic ConditionsUnited States
-
University of MinnesotaHennepin County Medical Center, Minneapolis; Minnesota Office of Higher EducationRecruitingIntracranial Pressure IncreaseUnited States
-
Carevive Systems, Inc.CompletedBreast Cancer | Gynecologic Cancer | Lung CancerUnited States
-
Siemens Medical Solutions USA - CSGCompletedBreast CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials GroupCompleted
-
Hoffmann-La RocheCompletedBreast NeoplasmsCanada, United States, France, Korea, Republic of, Spain, Belgium, Germany, Russian Federation, Taiwan, Ukraine
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); GlaxoSmithKline; Rutgers Cancer Institute of...TerminatedBreast Cancer - Female | Unspecified Adult Solid Tumor - Protocol SpecificUnited States
-
Wake Forest University Health SciencesCompletedInfections | Breast Reconstruction | MastectomyUnited States
-
University of California, San DiegoHaus of VoltaCompletedQuality of Life | Breast Cancer | Physical ActivityUnited States
-
Roxane LaboratoriesCompleted
-
The University of Texas Health Science Center at...Completed
-
East Carolina UniversityCompletedQuality of Life | Breast Cancer | Physical ActivityUnited States
-
Roxane LaboratoriesCompleted
-
Roxane LaboratoriesCompleted
-
Colorado State UniversityCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
Novartis PharmaceuticalsCompleted
-
TakedaUC San Diego Human Milk Research BiorepositoryRecruitingChronic Idiopathic Constipation (CIC)United States
-
Mentor Worldwide, LLCNo longer available
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
MacroGenicsRecruitingMelanoma | Sarcoma | Clear Cell Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Advanced Solid Tumor | Endometrial Cancer | Small-cell Lung Cancer and other conditionsUnited States, Australia, United Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedSarcoma | Lymphoma | Breast Cancer | Head and Neck Cancer | Metastatic Cancer | Non-melanomatous Skin CancerUnited States
-
Mayo ClinicWithdrawnMalignant Solid Neoplasm | Breast Carcinoma | Head and Neck Carcinoma | Lung Carcinoma | Esophageal Carcinoma | Malignant Brain NeoplasmUnited States
-
Chugai Pharma USACompletedBreast Cancer | Breast Neoplasms | MetastasisUnited States
-
M.D. Anderson Cancer CenterTerminatedHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Georgetown UniversityNational Cancer Institute (NCI); Virginia Commonwealth UniversityRecruitingHereditary Breast and Ovarian CancerUnited States
-
Hologic, Inc.CompletedBreast Cancer FemaleUnited States
-
TransThera Sciences (Nanjing), Inc.CompletedSarcoma | Gastric Cancer | Prostate Cancer | Cholangiocarcinoma | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Small-cell Lung Cancer | Thyroid Cancer | Gallbladder Cancer | HER2-negative Breast CancerUnited States
-
Carey Anders, M.D.PfizerActive, not recruitingAdvanced Breast Cancer | Brain Metastases | Human Epidermal Growth Factor 2 Positive Carcinoma of BreastUnited States
-
Melodi Health, Inc.Recruiting
-
The National Institute of LymphologyThe DrMarga Practice Group; The Center for Restorative Breast Surgery, LLCUnknownBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | Congenital Lymphedema | Acquired LymphedemaUnited States
-
University of South FloridaNational Cancer Institute (NCI)CompletedBreast Cancer | Fatigue | HypothyroidismUnited States
-
SandozSandoz GmbHCompletedBreast Cancer | Chemotherapy-induced NeutropeniaSpain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
Augusta UniversityNeolac Inc dba Medolac LaboratoriesUnknownPremature Infant | Breast Milk ExpressionUnited States
-
Indiana UniversityTerminatedAdenocarcinoma of the BreastUnited States
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine